综合一区欧美国产,99国产麻豆免费精品,九九精品黄色录像,亚洲激情青青草,久久亚洲熟妇熟,中文字幕av在线播放,国产一区二区卡,九九久久国产精品,久久精品视频免费

China / Society

Govt to give public better access to low-price drugs

By Shan Juan (China Daily) Updated: 2014-04-16 01:23

A multidepartment effort has been introduced to give the public better access to commonly used medications at a relatively low price.

Eight government departments, including the National Health and Family Planning Commission, the National Development and Reform Commission, the China Food and Drug Administration, and the Ministry of Finance, have issued a notice on securing a supply of commonly used low-price drugs.

Zheng Hong, the NHFPC's drug administration chief, said: "A list of such drugs is expected to be publicized by June, and the producers of the drugs will be entitled to the right of pricing according to production costs and the market situation."

The price limit that the government places on commonly used drugs will be eliminated under the new initiative, Zheng added.

The initiative comes in response to a series of shortages of commonly used and low-price drugs. Last year, people suffering from hyperthyroidism began reporting that they had difficulty buying the low-price medicine Tapazole.

A 100-tablet bottle of the drug costs around 2.5 yuan (40 US cents) while similar imported ones are priced more than 10 times that.

Liu Fengying, from Ankang, Shaanxi province, said she is concerned about the supply of Tapazole.

"I have to be on the medication, otherwise symptoms like weight loss, hair loss, muscle aches, fatigue and anxiety will come back," said Liu, who was diagnosed with hyperthyroidism five years ago.

Ma Jin, a professor at the public health department of Shanghai Jiao Tong University, said the Tapazole shortage was caused by issues with the country's essential drug system.

Introduced in 2009 as part of a series of medical reforms, the system controls the pricing of more than 500 types of drugs to help ensure that the public has access to cheap, high-quality medications. But the price controls cut into companies' profits, and some stopped producing commonly used low-price medicine, Ma said.

Mao Qun'an, spokesman for the NHFPC, conceded that the essential drug system was somewhat to blame for the occasional drug supply shortages.

Under the new initiative, producers of the listed drugs will enjoy more freedom to price the medicine according to real situations like the cost and market demands, Zheng Hong said.

"It's a dynamic approach as a regular drug supply and price surveillance system will lead to the introduction of new drugs to the list and also remove some others," he said.

Market competition will be encouraged to help maintain the price of drugs, he added.

Highlights
Hot Topics
...
和平区| 叙永县| 石嘴山市| 乌兰浩特市| 来凤县| 伊春市| 卫辉市| 夹江县| 南皮县| 德阳市| 原阳县| 东阳市| 隆德县| 韩城市| 武夷山市| 南汇区| 曲靖市| 蓬莱市| 台江县| 竹溪县| 贺兰县| 平乐县| 屏山县| 临猗县| 安多县| 正镶白旗| 巴林右旗| 布拖县| 茌平县| 永登县| 札达县| 临泽县| 烟台市| 灵山县| 兴国县| 图木舒克市| 永嘉县| 会同县| 临湘市| 晋州市| 游戏|